MacKenzie Sarvis is officially the first graduate student in the Drögemöller lab!
MacKenzie will be working on developing a polygenetic risk score to predict chemotherapy-induced ototoxicity (hearing loss) and using drug repurposing analyses to identify otoprotectants to prevent this debilitating adverse drug reaction.